OOIR: Observatory of International Research

Papers

(The H4-Index of Liver International is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Issue Information	219
Methylprednisolone‐Induced Liver Injury: Insights From FAERS Analysis and Comparison With DILIN Findings	121
Integrating PNPLA3 into clinical risk prediction	119
Prognostic Role of Endoscopic Ultrasound Guided Direct Portal Pressure Gradient Measurement in Porto‐Sinusoidal Vascular Disorder	93
HBV cure—The light at the end of the tunnel?	88
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct‐acting antivirals	88
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank	81
Causal effect of lower birthweight on non‐alcoholic fatty liver disease and mediating roles of insulin resistance and metabolites	78
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort	70
Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta‐analysis	69
Importance of gender differences in body composition for liver transplantation and the ‘Sarco‐Model’ study	67
Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort	62
Navigating portal hypertension: Unlocking safe passage to healthy pregnancy in EHPVO	62
Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study	62
Is ageing a problematic hurdle to the efficacy of first‐line atezolizumab plus bevacizumab in hepatocellular carcinoma?	60
Inside Front Cover	60
Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients	57
Changing epidemiological features of hepatocellular carcinoma: Taiwan's position	55
Letter to the Editor regarding “Long‐term exposure to air pollution and incident non‐alcoholic fatty liver disease and cirrhosis”	55
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease	54
Different methodologies of protein induced by vitamin K absence or antagonist II in patients without hepatocellular carcinoma	54
High disease burden and healthcare resource usage in patients with acute porphyria—A population‐based analysis	53
Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT‐FOXO3 signalling pathway	53
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib	53
Issue Cover	52

A population‐based study of pyogenic liver abscess in Korea: Incidence, mortality and temporal trends during 2007‐2017	51
Interpreting elevated liver blood test results through a genetic lens: A genome‐wide association study	49
Think twice about IgG4‐related diseases before operating on hepatic masses	48
Is fresh frozen plasma transfusion associated with outcomes in acute variceal bleeding?	47
The integrated stress response‐related expression of CHOP due to mitochondrial toxicity is a warning sign for DILI liability	45
High prevalence of porto‐sinusoidal vascular disease in patients with constantly elevated gamma‐glutamyl transferase levels	45
Golexanolone improves fatigue, motor incoordination and gait and memory in rats with bile duct ligation	44
Perilipin 5 protects the mitochondrial oxidative functions and improves the alcoholic liver injury in mice	44
Acute‐on‐chronic liver failure: Where do we stand?	43
EpCam is required for maintaining the integrity of the biliary epithelium	43
Impact of major depression and antidepressant use on alcoholic and non‐alcoholic fatty liver disease: A population‐based study	42
An ultrasound image‐based deep multi‐scale texture network for liver fibrosis grading in patients with chronic HBV infection	42
Abnormal cholesterol metabolism underlies relative adrenal insufficiency in decompensated cirrhosis	41
Profiles of liver fibrosis evolution during long‐term tenofovir treatment in HIV‐positive patients coinfected with hepatitis B	41
Proprotein convertase subtilisin/kexin type 9 regulates the production of acute‐phase reactants from the liver	40